Related Experiment Video
Updated: Jun 15, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk
Chih-Chiang Hung1, Chung-Lin Tsai2, Yu-Ting Chin3,4
1Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Background/Aim:
Matrix metalloproteinase-2 (MMP-2) has been implicated in the pathogenesis of breast cancer (BC). However, there is limited research on the role of MMP-2 genotypes in BC risk. This study aimed to investigate the associations between two MMP-2 promoter polymorphisms, rs243865 and rs2285053, and BC risk.
Materials And Methods:
MMP-2 genotypes were analyzed using PCR-based RFLP methodology in a cohort comprising 1,232 BC cases and 1,232 controls.
Results:
Genotypic frequencies of MMP-2 rs243865 and rs2285053 in controls were consistent with Hardy-Weinberg equilibrium (p=0.3702 and 0.2036, respectively). There were no significant differences in the distribution of rs243865 and rs2285053 genotypes between BC cases and controls (p for trend=0.1602 and 0.2170, respectively). Variant genotypes at rs243865 and rs2285053 appeared to confer a protective effect, although not statistically significant (all p>0.05). Similarly, the variant T allele at rs243865 and rs2285053 showed a non-significant trend towards decreased BC risk (OR=0.84 and 0.89, 95%CI=0.69-1.02 and 0.78-1.02, p=0.0811 and 0.1043, respectively). There was no interaction observed between MMP-2 rs243865 or rs2285053 genotypes and age. Stratified analysis did not reveal significant associations between MMP-2 rs243865 or rs2285053 genotypes and triple-negative breast cancer (TNBC) (p=0.6458 and 0.8745, respectively). Among both TNBC and non-TNBC cases, none of the variant genotypes at rs243865 or rs2285053 showed significant associations with TNBC (all p>0.05).
Conclusion:
MMP-2 rs243865 and rs2285053 genotypes appear to have a minimal impact on individual susceptibility to BC or TNBC.
Insights
Matrix metalloproteinase-2 (MMP-2) gene variants rs243865 and rs2285053 do not significantly impact breast cancer (BC) risk. These MMP-2 genotypes show a minimal effect on individual susceptibility to BC or triple-negative breast cancer (TNBC).
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Matrix metalloproteinase-2 (MMP-2) is linked to breast cancer (BC) pathogenesis.
- Limited research exists on the association between MMP-2 genotypes and BC risk.
Purpose of the Study:
- To investigate the relationship between MMP-2 promoter polymorphisms (rs243865 and rs2285053) and breast cancer risk.
- To explore the impact of these genotypes on triple-negative breast cancer (TNBC) susceptibility.
Main Methods:
- Genotyping of MMP-2 rs243865 and rs2285053 using PCR-based RFLP.
- Analysis of a cohort including 1,232 breast cancer cases and 1,232 controls.
Main Results:
- No significant differences in genotype distributions of rs243865 and rs2285053 between BC cases and controls.
- Variant genotypes and alleles showed a non-significant trend towards decreased BC risk.
- No significant associations were found between MMP-2 genotypes and TNBC risk.
Conclusions:
- MMP-2 rs243865 and rs2285053 genotypes have a minimal impact on breast cancer susceptibility.
- These specific MMP-2 polymorphisms do not appear to influence individual risk for BC or TNBC.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mutagenicity and Carcinogenicity
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...